Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Singapore Perioperative Ageing Study (Sing-PAS)
Authors not listed
National University Hospital, Singapore · 2021
Abstract
The specific aim of the study will be to set up a perioperative database to longitudinally track the progress of elderly patients undergoing major surgery from the preoperative period to five years postoperatively. This database will form the foundation of a programme that will be sustainable through future grants to implement clinical strategies to improve outcomes.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-07-02 MST
Cite this
APA
Anonymous. (2021). Singapore Perioperative Ageing Study (Sing-PAS). <em>National University Hospital, Singapore</em>. https://clinicaltrials.gov/study/NCT04792554
Vancouver
Anonymous. Singapore Perioperative Ageing Study (Sing-PAS). National University Hospital, Singapore. 2021.
BibTeX
@misc{anon2021Singap,
title = {Singapore Perioperative Ageing Study (Sing-PAS)},
author = {Anonymous},
journal = {National University Hospital, Singapore},
year = {2021},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Amway (China) R&D Center 2023
Open access · US-GOV
A Randomized, Double-blind Controlled Trial to Investigate Effects of Amway Bundle Combination of Products on Osteoarthritis & Sarcopenia
Memorial University of Newfoundland 2017
Open access · US-GOV
Implementing and Testing a Cardiovascular Assessment Screening Program to Promote Healthy Aging (CASP)
Beijing Chao Yang Hospital 2025
Open access · US-GOV
A Individualized Physical Function Improvement Program for Frailty Elderly Using Goal Attainment Scaling (GAS) as Evaluation Method: Protocol for a Randomized Controlled Trial
Celgene 2016
Open access · US-GOV
Retrospective Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms
University of Washington 2003
Open access · US-GOV
Telehealth for Diabetes Self-Management
Bayer 2016
Open access · US-GOV